Lv45
750 积分 2021-04-26 加入
Paneth-like transition drives resistance to dual targeting of KRAS and EGFR in colorectal cancer
20天前
已完结
Secular trend in disease burden of leukemia and its subtypes in China from 1990 to 2019 and its projection in 25 years
20天前
已完结
A Story of Hypofractionation and the Table on the Wall
1个月前
已完结
SCRN1 confers hepatocellular carcinoma resistance to ferroptosis by stabilizing GPX4 via STK38-mediated phosphorylation
1个月前
已完结
p53 induces circFRMD4A to suppress cancer development through glycolytic reprogramming and cuproptosis
1个月前
已完结
Unveiling the Landscape of Uncommon EGFR Mutations in NSCLC-A Systematic Review
3个月前
已完结
Receptor tyrosine kinase fusion-mediated resistance to EGFR-TKI in EGFR-mutant NSCLC: a multi-center analysis and literature review
3个月前
已完结
Potent antitumor activity of ensartinib in MET exon 14 skipping-mutated non-small cell lung cancer
3个月前
已完结
The changing treatment landscape of EGFR-mutant non-small-cell lung cancer
3个月前
已完结
Limertinib for EGFR mutation-positive NSCLC treatment
3个月前
已关闭
皖公网安备34019202002308
